[Implication of piribedil (pronoran) in the treatment of Parkinson's disease; a clinical and pharmacoeconomic analysis]

Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):49-55.
[Article in Russian]
No abstract available

Publication types

  • Review

MeSH terms

  • Antiparkinson Agents / economics*
  • Antiparkinson Agents / therapeutic use*
  • Costs and Cost Analysis
  • Economics, Pharmaceutical / statistics & numerical data*
  • Humans
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / economics
  • Piribedil / economics*
  • Piribedil / therapeutic use*
  • Treatment Outcome

Substances

  • Antiparkinson Agents
  • Piribedil